Tokyo Tape
Sign in
← Fukuda Denshi

Half-year report · Q2

6960.TEDINET S100UR0K
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥64.3bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥140.3bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥66.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥10.7bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥14.0bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥11.3bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥27.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥14.1bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥11.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥14.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥7.7bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥18.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥7.7bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥204.8bnat 2024-09-30Cons.Assets
Total assets¥209.1bnat 2024-03-31Cons.Assets
Total assets¥210.8bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥32.8bnat 2024-09-30Cons.Liabilities
Total liabilities¥40.1bnat 2024-03-31Cons.Liabilities
Net assets / equity¥172.0bnat 2024-09-30Cons.Net assets
Net assets / equity¥169.0bnat 2024-03-31Cons.Net assets
Net assets / equity¥171.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥64.2bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥60.2bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥61.2bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥57.2bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥67.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥14.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥10.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥14.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥17.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥267.342024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥622.442023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥324.322023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio84.0%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥17.8bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥17.8bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.6bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥30.5bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥30.5bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥5.6bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥658m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥11.9bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥11.9bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥64.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥64.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥10.7bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.7bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥737m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥14.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Other caPrior1YearInstant2076000000JPY
Other caCurrentQuarterInstant2504000000JPY
Allowance for doubtful accounts caPrior1YearInstant-38000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-36000000JPY
Current assetsPrior1YearInstant119136000000JPY
Current assetsCurrentQuarterInstant113394000000JPY
Property plant and equipmentPrior1YearInstant51575000000JPY
Property plant and equipmentCurrentQuarterInstant53480000000JPY
Intangible assetsPrior1YearInstant1862000000JPY
Intangible assetsCurrentQuarterInstant1770000000JPY
Investment securitiesPrior1YearInstant15496000000JPY
Investment securitiesCurrentQuarterInstant13995000000JPY
Other ioaPrior1YearInstant21000000000JPY
Other ioaCurrentQuarterInstant22142000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-6000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-7000000JPY
Investments and other assetsPrior1YearInstant36489000000JPY
Investments and other assetsCurrentQuarterInstant36130000000JPY
Noncurrent assetsPrior1YearInstant89928000000JPY
Noncurrent assetsCurrentQuarterInstant91382000000JPY
AssetsPrior1YearInstant209064000000JPY
AssetsCurrentQuarterInstant204776000000JPY
Notes and accounts payable tradePrior1YearInstant11611000000JPY
Notes and accounts payable tradeCurrentQuarterInstant9721000000JPY
Electronically recorded obligations operating clPrior1YearInstant4753000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant3218000000JPY
Short term loans payablePrior1YearInstant1750000000JPY
Short term loans payableCurrentQuarterInstant1800000000JPY
Income taxes payablePrior1YearInstant3856000000JPY
Income taxes payableCurrentQuarterInstant3180000000JPY
Provision for product warrantiesPrior1YearInstant149000000JPY
Provision for product warrantiesCurrentQuarterInstant160000000JPY
Provision for bonusesPrior1YearInstant3816000000JPY
Provision for bonusesCurrentQuarterInstant3066000000JPY
Other provision clPrior1YearInstant547000000JPY
Other provision clCurrentQuarterInstant273000000JPY
Other clPrior1YearInstant7947000000JPY
Other clCurrentQuarterInstant5892000000JPY
Current liabilitiesPrior1YearInstant34431000000JPY
Current liabilitiesCurrentQuarterInstant27313000000JPY
Net defined benefit liabilityPrior1YearInstant2031000000JPY
Net defined benefit liabilityCurrentQuarterInstant2051000000JPY
Other provision nclPrior1YearInstant810000000JPY
Other provision nclCurrentQuarterInstant739000000JPY
Other nclPrior1YearInstant2782000000JPY
Other nclCurrentQuarterInstant2696000000JPY
Noncurrent liabilitiesPrior1YearInstant5624000000JPY
Noncurrent liabilitiesCurrentQuarterInstant5486000000JPY
LiabilitiesPrior1YearInstant40056000000JPY
LiabilitiesCurrentQuarterInstant32800000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass